BBT-877

DRUG2 trials

Sponsors

Bridge Biotherapeutics, Inc.

Conditions

Healthy ParticipantsIdiopathic Pulmonary Fibrosis

Phase 1

Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects

CompletedNCT04138836

Bridge Biotherapeutics, Inc.Healthy Participants

Start: 2019-09-17End: 2019-11-04Updated: 2020-01-18

Phase 2

To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

CompletedNCT05483907

Bridge Biotherapeutics, Inc.Idiopathic Pulmonary Fibrosis

Start: 2023-04-12End: 2025-02-23Updated: 2025-04-01

Related Papers

Phase 2 study design and analysis approach for BBT-877: an autotaxin inhibitor targeting idiopathic pulmonary fibrosis

BMJ Open Respiratory Research2025-05-012 citations